{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T19:11:25Z","timestamp":1792350685131,"version":"4.4.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/infdis\/jiz077","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T04:19:03Z","timestamp":1550463543000},"source":"Crossref","is-referenced-by-count":6,"title":["Sabin Strain Inactivated Polio Vaccine for the Polio Endgame"],"prefix":"10.1093","author":[{"given":"John F","family":"Modlin","sequence":"first","affiliation":[{"name":"Bill and Melinda Gates Foundation, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Chumakov","sequence":"additional","affiliation":[{"name":"Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"key\n\t\t\t\t2019033003593921400_CIT0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(17)32442-X","article-title":"The polio endgame: securing a world free of all polioviruses","volume":"391","author":"Zaffran","year":"2018","journal-title":"Lancet"},{"issue":"Pt 5","key":"key\n\t\t\t\t2019033003593921400_CIT0002","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1099\/0022-1317-69-5-1091","article-title":"The effect of sequences in the 5\u2019 non-coding region on the replication of polioviruses in the human gut","volume":"69","author":"Minor","year":"1988","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t2019033003593921400_CIT0003","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"key\n\t\t\t\t2019033003593921400_CIT0004","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"key":"key\n\t\t\t\t2019033003593921400_CIT0005","unstructured":"Global Polio Eradication Initiative. Wild poliovirus weekly update.http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek.aspx. Accessed 30 January 2019."},{"key":"key\n\t\t\t\t2019033003593921400_CIT0006","first-page":"1","article-title":"Polio endgame: the global introduction of inactivated polio vaccine","author":"Patel","year":"2015","journal-title":"Exp Rev Vaccines"},{"key":"key\n\t\t\t\t2019033003593921400_CIT0007","volume-title":"WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use (GAPIII)","author":"World Health Organization (WHO)","year":"2015"},{"key":"key\n\t\t\t\t2019033003593921400_CIT0008","doi-asserted-by":"crossref","first-page":"30169","DOI":"10.2807\/1560-7917.ES.2016.21.11.30169","article-title":"Risk assessment, risk management and risk-based monitoring following a reported accidental release of poliovirus in Belgium, September to November 2014","volume":"21","author":"Duizer","journal-title":"Euro Surveill 2016"},{"key":"key\n\t\t\t\t2019033003593921400_CIT0009","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00006454-198811000-00003","article-title":"Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey","volume":"7","author":"Murph","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t2019033003593921400_CIT0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.biologicals.2016.08.005","article-title":"Development of inactivated poliovirus vaccine from Sabin strains: a progress report","volume":"44","author":"Okayasu","year":"2016","journal-title":"Biologicals"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiz077\/28250070\/jiz077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T07:59:49Z","timestamp":1553932789000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/advance-article\/doi\/10.1093\/infdis\/jiz077\/5351111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":10,"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz077","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]}}}